$RYM

RYTHM, Inc. (RYM): Results of Operations and Financial Condition

RYTHM, Inc. (RYM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ea029949501ex99-1.htm PRESS RELEASE OF RYTHM, INC. DATED AUGUST 4, 2026 Exhibit 99.1 RYTHM, Inc. Reports Second Quarter 2026 Results ROLLING MEADOWS, IL, August 4, 2026 (GLOBE NEWSWIRE) – RYTHM, Inc. (Nasdaq: RYM) (“RYTHM” or the “Company”), America’s THC Company whose

Original reporting
Published Aug 4, 2026, 11:05 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 11:33 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$RYM
Bullish
medium confidence
Mentioned
$RYM
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$RYMBullishMed
01

Why it matters

The combination of strong Q2 financials and a withheld Q3 outlook creates a two-sided setup: near-term fundamentals improve, but forward risk is elevated and timing-sensitive around Nov 12, 2026 regulatory changes.

02

Market read

Traders get fresh Q2 datapoints (revenue, cash, net income, adjusted EBITDA) and a clear forward guidance constraint tied to federal regulatory timing, which can drive both momentum and risk repricing.

03

What to watch

The release notes fixed annual cash licensing fees from Green Thumb took effect April 1, 2026, so traders should separate underlying demand trends from the step-up in licensing economics when assessing sustainability.

Relevance 7/10Novelty 8/10Timing: filed pre-market today, Q2 results and Q3 outlook decision disclosed

Background

RYTHM filed an 8-K with its Q2 2026 results and a company press release (Exhibit 99.1), including operating highlights and a decision not to provide Q3 outlook due to impending federal law changes.

Company-level read

Ticker impact

$RYMBullishMedium confidence
Context

RYM reported Q2 2026 results, including $23.0M revenue from continuing operations (+73% QoQ) and $6.4M adjusted EBITDA, plus a regulatory outlook pause for Q3.

Expected impact

Near-term upside bias on the earnings beat and cash generation, with increased volatility risk around the Nov 12, 2026 regulatory uncertainty and lack of Q3 guidance.

Evidence & confidence

The release provides multiple concrete operating metrics (revenue, cash, net income, adjusted EBITDA) and explicitly states no Q3 outlook because of forthcoming federal law changes, which can reprice risk and expectations.

Market effects

Reinforces demand momentum for THC beverages and highlights how federal hemp-derived THC regulatory timelines can directly affect guidance and valuation risk across the category.

Limited direct regional read-through; brand partnerships are US-focused (Lollapalooza, Opry, Navy Pier).

Low, as the disclosure is company-specific and US regulatory-driven.

Counterpoint

The headline growth may be partly licensing-driven and could reverse if federal law changes reduce market access or alter product economics after Nov 12, 2026.

Key entities

  • RYTHM, Inc.

    Nasdaq-listed THC beverage and hemp-derived product company reporting Q2 2026 results and pausing Q3 outlook due to federal law uncertainty.

  • Green Thumb Industries Inc.

    Licensing fee counterparty; fixed annual cash licensing fees of $70M took effect April 1, 2026.

  • Lollapalooza

    Named as a venue where Señorita is the official THC beverage partner.

  • Opry Entertainment Group

    Named as a venue partner for Señorita as official THC beverage partner.

  • Chicago’s Navy Pier

    Named as a venue where RYTHM is the official THC beverage partner.

Related articles

$RYMMedAI 8/10

Daily NZX update, Friday, June 5, 2026

NZX 50 was up 0.3% at 3:00pm, though down 0.5% over five days and 2.6% over six months. Top gainers included Air New Zealand (+2%), Mainfreight (+2%) and Genesis Energy (+2%); biggest fallers were Kathmandu (-3%), A2 Milk (-2%) and Tourism Holdings (-2%). SmartShares ETFs were mixed. Meridian welcomed a draft Fast-track Panel decision on Lake Pūkaki access; Infratil completed a $200m capital bond offer; Ryman reported FY26 EBITDAF $88.3m and free cash flow $188.3m.

$RYMMedAI 8/10

Daily NZX update, Wednesday, June 3, 2026

NZX50 was down 0.3% at 3:00pm, though up 0.4% over five sessions and 6.5% over 12 months. Gentrack Group led gainers (+4%), while Vista Group fell the most (-3%). Ebos (-3%) and A2 Milk (-1%) also declined. Ryman Healthcare is considering new six-year secured bonds; Scales Corp declared a 12.5c FY2025 final dividend; Pacific Edge raised NZ$36.1m at NZ$0.17/share.

$KDMed

Kyndryl Q1 Earnings Call Highlights

Kyndryl (NYSE:KD) Q1 call said demand is rising for AI deployment, hybrid modernization, cybersecurity and data-residency. It reported 40 deals worth over $50M in 12 months, with 10 in Q1, and Kyndryl Consult signings up 50%. IBM relationship changes are expected to weigh on constant-currency revenue through FY2027. FCF was -$401M; cash $2.1B. Outlook FY2027 reaffirmed.

$KAIMedAI 8/10

Kadant Q2 Earnings Call Highlights

Kadant (NYSE:KAI) reported Q2 equipment backlog of $182 million and said aftermarket demand stayed at record or near-record levels. Flow Control revenue rose 5% to $100 million; Industrial Processing revenue rose to a record $144 million; Material Handling bookings were $73 million. Q2 gross margin fell to 43.8%. Kadant raised FY revenue guidance to $1.19-$1.21B and adjusted EPS to $12.43-$12.68.

$KRPMed

Kimbell Royalty Q2 Earnings Call Highlights

Kimbell Royalty (NYSE:KRP) reported record Q2 adjusted EBITDA of $84.9 million, with cash G&A of $5.9 million ($2.50 per BOE). It declared a $0.47 per common unit cash distribution, up 15% QoQ, and said 47% may be return of capital. The borrowing base rose to $660 million; debt was $478.7 million. Rig activity and production varied by basin.

$KMPRMed

Kemper Q2 Earnings Call Highlights

Kemper (NYSE:KMPR) reported Q2 results and discussed credit-loss allowances tied to surplus notes in its reciprocal exchange, including a $21 million pre-tax charge on $36 million of notes. Holding-company liquidity was $766 million and debt-to-capital rose to 28.3%. Personal auto normalized combined ratio was 102% and commercial 93.7%, with California rate actions and restructuring savings over $80 million run-rate.